Home Press Releases Life Science Reagents Market Expected to Reach USD 25.7 Billion Globally in 2019
Life Science Reagents Market Expected to Reach USD 25.7 Billion Globally in 2019
According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “Life Science Reagents Market (Products- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- Commercial and Contract Manufacturers, Research and Academic Institutions, Clinical Laboratories, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, the global life science reagents market was valued at USD 12.44 billionin 2012and is expected to grow at a CAGR of 10.8%from 2013 to 2019, to reach an estimated value of USD 25.73billion in 2019.
Browse the full Life Science Reagents Market report at http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html
Being predominantly used in a wide range of analytical and manufacturing processes,reagents areone of the fastest moving and widely consumed products in the life science industry. Factors such as rise in the number of government initiatives for the growth of biotechnology industry and advancement in related technologies will have a tremendous impact on the growth of the life science reagents market.
Amongst the various typesof commercially available life science reagents, chromatography and in-vitro diagnostic reagents were the largest product segments in 2012, with a cumulative market share of more than 50% in the overall life science reagents market. In addition, the polymerase chain reaction (PCR) reagent kits market is expected to cannibalizethe market share of other product segments during the forecast perioddue to expansion of its application area from only commercial manufacturing to in-vitro diagnostics.It is expected that the global market for polymerase chain reaction (PCR) reagent kits will reach USD 4.26billion in 2019 growing at a CAGR of 14.2%from 2013 to 2019.
Research and academic institutes from the largest set of consumers, by revenue, of life science reagents. Growth in research and development activities by biotechnology companies with an intention to introduce breakthrough technologies in the market has led to rise in consumption of life science reagents in related processes.
Geographically, North America dominated the global life science reagents marketin 2012 mainly due to the advantage of bigger patent repositorywith biotechnology companies based in this region.Factors that will drive future growthof the North American life science reagents market include existence of supportive economic base, highly developed research infrastructure, technological advancement and higher adoption rate of those technologies.
However,countries in the Asia-Pacificregion such as China, Japan and India are expected to be potential markets with high prevalence of infectious diseases, development of healthcare infrastructure, aging of population resulting in rising incidencesof cardiac diseases, increasing government initiatives to boost the biotechnology industry in the respective countries and rapidly increasing awareness about disease diagnosis and prevention.
The global life science reagents market is characterized by the presence of a largenumber of market players. The matured market players intensively follow predatory business strategies such as acquisition of small market entrants with breakthrough technologies. Some of the key participants operating in this market includeAbbott laboratories, Agilent Technologies, bioMerieux, Life Technologies Corporation, Bio-Rad Laboratories, Inc., GE Healthcare, Merck Millipore, Sigma Aldrich Corporation and Lonza Group Ltd.
The global life science reagentsmarket is segmented as follows:
Life Science Reagents Market, by Product Type
- Polymerase chain reaction (PCR) reagent kits
- Cell and tissue culture reagents
- Flow cytometry reagents
- Electrophoresis reagents
- Chromatography reagents
- In-vitro diagnostic (IVD) reagents
Life Science Reagents Market, by End User
- Commercial and contract manufacturers
- Research and academic institutions
- Clinical laboratories
- Forensic laboratories
Life Science Reagents Market, by Geography
- North America
- Rest of the World (RoW)
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Ms. Sheela AK
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
- Bispecific Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
Bispecific antibodies are recognized as artificial protein where two or more antigen recognizing elements are combining together to form a single construct. Bispecific antibodies are able to bind into two or more targets at a time. Moreover, these antibodies might bridge two targets together and are able to present high chances of gaining therapeutic effects (bring cancer cell within striking distance). The various formats of bispecific antibodies include quadromas, chemical heteroconjugates,...
- Epidermal Growth Factor Receptor (EGFR) Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
The epidermal growth factor receptor (EGFR) is defined as a transmembrane tyrosine kinase receptor involved in the survival and proliferation of the cancerous cells. Any kind of mutations affecting these EFGR receptors or activity could results in cancer. Mutations lead to over-expresion resulting in large number of cancer, including lung cancer, anal cancer and glioblastoma multiforme. EGFR receptors are the first molecule target against which monoclonal antibodies (mAb) have been designed f...
- Recombinant Therapeutic Antibodies & Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
Human proteins obtained through genetic engineering rather than from tissue samples have played a vital role in therapeutic medicines market. Advances in pharmacological understanding and pharmaceutical production have allowed continuous development of human proteins as a vital therapeutic option in variety of human diseases. From a clinical perspective, therapeutic proteins provide essential therapies in various life threatening disease such as diabetes, viral hepatitis, end-stage renal dise...